The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://royngtx991754.ktwiki.com/1937063/retatrutide_vs_tirzepatide_a_comparative_analysis